← Back to Clinical Trials
Recruiting NCT04130269

NCT04130269 Anxiety, Stress and Pain & Myocardial Infarction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04130269
Status Recruiting
Phase
Sponsor Medical University of Graz
Condition Myocardial Infarction
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2020-04-07
Primary Completion 2027-12-07

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age 90 Years
Study Type OBSERVATIONAL
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2020-04-07 with a primary completion date of 2027-12-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing Posttraumatic Stress Disorder (PTSD) after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress, and PTSD after an acute myocardial infarction.

Eligibility Criteria

Inclusion Criteria: * willingness to participate in the study * men and women 19-90 * after myocardial infarctions * no psychiatric disease before myocardial infarction * no other severe disease influencing the immune system Exclusion Criteria: * non fulfilment of inclusion criteria * non-compliant patients (dementia, delirium) * steroid-therapy

Contact & Investigator

Central Contact

Andreas Baranyi, MD

✉ an.baranyi@medunigraz.at

📞 004331638513612

Frequently Asked Questions

Who can join the NCT04130269 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, up to 90 Years, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04130269 currently recruiting?

Yes, NCT04130269 is actively recruiting participants. Contact the research team at an.baranyi@medunigraz.at for enrollment information.

Where is the NCT04130269 trial being conducted?

This trial is being conducted at Graz, Austria.

Who is sponsoring the NCT04130269 clinical trial?

NCT04130269 is sponsored by Medical University of Graz. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology